The global ophthalmic lasers market is anticipated to grow from a market value of US$ 884.3 Mn in 2022 to US$ 1.3 Bn by 2030, expanding at a moderate CAGR of 5.4%.
Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market growth is no exception. Over the years, ophthalmic disorders such as diabetic retinopathy, refractive errors, glaucoma, cataract and age related macular degeneration (AMD) have surged exponentially. This has accelerated demand for advanced surgical procedures.
The introduction of ophthalmic laser surgery has revolutionized ophthalmic care in unprecedented ways. Majority of these technologies are being deployed in cataract surgeries, attributed to the disorder’s widespread prevalence across all continents. Advancements such femtosecond laser surgeries have proven highly instrumental in streamlining ophthalmic procedures, offering lightning speed detection of faulty tissues.
Such reduced detection and treatment timeframes act as major growth catalysts for the global ophthalmic lasers market, which is anticipated to reach a value of US$ 1.3 Bn by 2030.
Consumers have long placed a high importance on keeping good eye health in order to preserve their vision. The market size for ophthalmic laser machines is expanding, providing attractive prospects for ophthalmic laser producers thanks to rising spending on keeping good eye health and rising awareness of various ophthalmic disorders.
Growing consumer desire for minimally invasive laser treatments and the quick expansion of the eye infection treatment market have a significant impact on ophthalmic laser sales.
Ophthalmic lasers are special treatments used to repair damaged corneas and treat disorders that might impair vision, including glaucoma, macular degeneration, and diabetic retinopathy. Due to their safe, precise, and accurate character, they have grown to be highly sought-after goods utilised in surgical treatment for a variety of eye problems.
Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1529
As diabetes incidence increases globally, there has been a noticeable increase in the number of prevalent ocular problems over the past few years, including cataract, glaucoma, and others. During the projected period, this is anticipated to offer a favourable environment for the leading producers of ophthalmic laser devices.
The market for ophthalmic laser devices is therefore growing as there is a growing preference for safe and efficient techniques like laser vision correction (LVC) to do away with the necessity for glasses or contact lenses.
During the evaluation period, it is also anticipated that the market for laser therapy equipment would thrive and that the popularity of minimally invasive surgeries will increase.
Ophthalmic laser sales made up around 41% of the US$ 2.0 Billion global market for laser therapy equipment in 2021, according to Future Market Insights (FMI).
Leading producers of ophthalmic lasers are anticipated to spend more on improved product designs and technological advancements in order to offer ophthalmologists cutting-edge products for use in routine ocular procedures. Due to this, demand for ophthalmic laser equipment will increase during the ensuing time.
Ophthalmic Lasers Market- Key Highlights
“Vendors in the ophthalmic lasers landscape are striving to introduce novel product lines, equipped with multi-frequency selection modes to reduce exposure to intense laser bursts, preventing healthy tissue damage,” infers the FMI analyst.
Get In Touch With Our Team For 20% Flat Discount: https://www.futuremarketinsights.com/ask-question/rep-gb-1529
Prominent vendors in the ophthalmic lasers market include are ZEISS International, Nidek Inc., Bausch & Lomb Inc., Abbot Laboratories Inc., SCHWIND Eye-Tech Solutions, Ziemer Ophthalmic Systems AG, Novartis AG (Alcon), LENSAR LLC., iVIS Technologies and NKT Photonics A/S. New product launches and collaborations have helped these players acquire firm footing.
In 2018, ZEISS International rolled out its VISUFIT 1000 digital 3D centration data determination and consultation platform, offering a three-dimensional facial reconstruction which enables ophthalmologists perform precise centration processes on patients.
In July 2022, SCHWIND Eye-Tech acquired CE approval for its SCHWIND ATOS femtosecond laser, permitting eye surgeons to incorporate the technology in their SmartSight refractive surgery procedures.
More Insights on the Ophthalmic Lasers Market
A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2014-2021 & opportunity assessment for 2022-2030, and delivers a comprehensive assessment of the most important market dynamics. The report provides a balanced, unbiased analysis of the overall market scenario based on product type (excimer lasers and femtosecond lasers), application (refractive surgery, cataract surgery, capsulotomy, trabeculoplasty and diagnostics), end-user (hospitals, ophthalmology clinics and ambulatory surgical centers) and region (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).
Request for Customization: https://www.futuremarketinsights.com/customization-available/REP-GB-1529
Ophthalmic lasers market by Category
Top Related Reports Healthcare Market Insights
https://loop.joshwho.net/posts/27910200?utm_source=manual
https://www.xaphyr.com/blogs/158814/Body-Contouring-Market-Creating-Opportunity-Demands-Supply-Value-Chain-Process
https://app.goodnightjournal.com/journal/0d58c176-1eb4-433e-97b2-5ba8d11a8e9a
https://www.zedlike.com/blogs/18488/Body-Contouring-Market-Segmentation-Application-Technology-Analysis-Research-Report-To
https://social.noncense.org/read-blog/10840
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights, Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware – 19713, USA T: +1-845-579-5705 For Sales Enquiries: sales@futuremarketinsights.com Browse All Reports: https://www.futuremarketinsights.com/reports LinkedIn| Twitter| Blogs
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2022 PHARMIWEB.COM LIMITED, rights reserved by the relevant holders.
You are leaving PharmiWeb.com
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE
PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com.
PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information.
Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely.
If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.